Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens. [electronic resource]
Producer: 20130808Description: 42-50 p. digitalISSN:- 1873-2496
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Bone Neoplasms -- metabolism
- Carcinoma, Renal Cell -- metabolism
- Combined Modality Therapy
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Kidney Neoplasms -- metabolism
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Staging
- Nephrectomy -- mortality
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Prognosis
- Sorafenib
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.